Townsquare Capital LLC trimmed its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 45.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,796 shares of the company's stock after selling 23,917 shares during the quarter. Townsquare Capital LLC's holdings in Kenvue were worth $615,000 as of its most recent filing with the SEC.
Other hedge funds have also recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. lifted its stake in Kenvue by 5.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 185,372 shares of the company's stock worth $3,958,000 after purchasing an additional 9,514 shares in the last quarter. Sterling Capital Management LLC lifted its position in Kenvue by 55.3% during the fourth quarter. Sterling Capital Management LLC now owns 114,247 shares of the company's stock worth $2,439,000 after buying an additional 40,694 shares in the last quarter. Zuckerman Investment Group LLC boosted its stake in Kenvue by 18.7% during the fourth quarter. Zuckerman Investment Group LLC now owns 1,122,061 shares of the company's stock worth $23,821,000 after buying an additional 176,632 shares during the last quarter. Treasurer of the State of North Carolina grew its holdings in Kenvue by 3.3% in the 4th quarter. Treasurer of the State of North Carolina now owns 864,896 shares of the company's stock valued at $18,466,000 after buying an additional 27,950 shares in the last quarter. Finally, Neuberger Berman Group LLC increased its stake in shares of Kenvue by 0.4% in the 4th quarter. Neuberger Berman Group LLC now owns 265,473 shares of the company's stock worth $5,668,000 after acquiring an additional 1,165 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have recently weighed in on KVUE. UBS Group lowered their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Piper Sandler increased their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Canaccord Genuity Group lifted their price target on shares of Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday, March 5th. Redburn Atlantic assumed coverage on Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective for the company. Finally, Evercore ISI started coverage on Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $24.42.
Check Out Our Latest Research Report on Kenvue
Kenvue Trading Down 1.0 %
Kenvue stock traded down $0.24 during midday trading on Wednesday, reaching $22.95. 13,014,749 shares of the stock traded hands, compared to its average volume of 17,120,790. The firm has a market cap of $44.03 billion, a PE ratio of 43.30, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The company has a 50-day simple moving average of $22.97 and a two-hundred day simple moving average of $22.41. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46.
Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be paid a $0.205 dividend. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.57%. Kenvue's dividend payout ratio (DPR) is 154.72%.
Kenvue Profile
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Read More
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
